Mackenzie Financial Corp Acquires 1,685 Shares of Chemed Co. (NYSE:CHE)

Mackenzie Financial Corp lifted its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 66.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,234 shares of the company's stock after acquiring an additional 1,685 shares during the quarter. Mackenzie Financial Corp's holdings in Chemed were worth $2,476,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in CHE. Larson Financial Group LLC acquired a new position in shares of Chemed during the third quarter worth $44,000. Legacy Financial Group LLC acquired a new position in Chemed in the 3rd quarter worth $48,000. Covestor Ltd boosted its position in Chemed by 27.4% in the 3rd quarter. Covestor Ltd now owns 144 shares of the company's stock valued at $75,000 after buying an additional 31 shares during the last quarter. ORG Partners LLC acquired a new stake in shares of Chemed during the third quarter valued at about $126,000. Finally, Silver Oak Securities Incorporated purchased a new stake in shares of Chemed during the third quarter worth about $126,000. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Chemed news, VP Brian C. Judkins sold 11,158 shares of the firm's stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $645.00, for a total value of $7,196,910.00. Following the completion of the transaction, the vice president now directly owns 1,422 shares in the company, valued at $917,190. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, EVP Spencer S. Lee sold 2,000 shares of the stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the completion of the sale, the executive vice president now owns 20,760 shares in the company, valued at $13,320,654. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Brian C. Judkins sold 11,158 shares of Chemed stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $645.00, for a total value of $7,196,910.00. Following the transaction, the vice president now owns 1,422 shares in the company, valued at approximately $917,190. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,808 shares of company stock valued at $10,184,531. 3.32% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Oppenheimer raised their price objective on Chemed from $625.00 to $650.00 and gave the company an "outperform" rating in a research note on Thursday, February 29th. Royal Bank of Canada lifted their price target on shares of Chemed from $604.00 to $712.00 and gave the stock an "outperform" rating in a research note on Monday, March 4th.

Chemed Trading Up 2.0 %

Chemed stock traded up $12.09 during midday trading on Tuesday, hitting $616.51. The stock had a trading volume of 87,319 shares, compared to its average volume of 77,608. The business has a fifty day moving average price of $622.33 and a 200 day moving average price of $589.76. Chemed Co. has a 12 month low of $492.84 and a 12 month high of $654.62. The stock has a market cap of $9.32 billion, a P/E ratio of 34.40, a P/E/G ratio of 2.41 and a beta of 0.42.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $6.60 earnings per share for the quarter, beating analysts' consensus estimates of $6.25 by $0.35. The company had revenue of $585.90 million during the quarter, compared to the consensus estimate of $586.64 million. Chemed had a net margin of 12.03% and a return on equity of 32.29%. Chemed's revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the company earned $5.39 EPS. On average, equities analysts anticipate that Chemed Co. will post 21.99 EPS for the current fiscal year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Monday, February 26th were given a $0.40 dividend. The ex-dividend date was Friday, February 23rd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.26%. Chemed's dividend payout ratio (DPR) is 8.93%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.